(ANDE) The Andersons - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0341641035
ANDE: Grain, Ethanol, Fertilizer, Commodities, Nutrients, Products
The Andersons, Inc. (NASDAQ:ANDE) is a diversified company with a strong presence in the agricultural and industrial sectors, operating across multiple countries including the U.S., Canada, Mexico, Egypt, Switzerland, and others. With a market capitalization of approximately $1.4 billion, the company is structured into three core segments: Trade, Renewables, and Nutrient & Industrial. This diversification allows it to balance risk and capitalize on opportunities across different markets.
The Trade segment is the backbone of the company, focusing on grain elevators, commodity storage, and marketing. It trades a wide range of commodities such as corn, soybeans, wheat, and ethanol, while also providing logistics and risk management services. This segment essentially acts as a critical link between producers and end-users, ensuring efficient flow of agricultural commodities. The Renewables segment builds on this by producing and selling ethanol, a key biofuel, along with co-products. By integrating its ethanol operations with its trade business, the company optimizes its supply chain and reduces transportation costs.
The Nutrient & Industrial segment rounds out the companys offerings, manufacturing and distributing agricultural fertilizers, industrial products, and specialty items like corncob-based products. This segment serves both farmers and industrial clients, providing essential nutrients for crops and raw materials for various industries. The companys ability to produce everything from turf fertilizers to deicers and dust abatement products highlights its versatility and deep understanding of its markets.
For investors, The Andersons, Inc. presents an interesting case. Its trailing P/E of 11.81 and forward P/E of 20.92 suggest expectations of growth, though the premium valuation may raise questions about near-term catalysts. The P/S ratio of 0.12 indicates modest revenue generation relative to its market cap, while the P/B ratio
Additional Sources for ANDE Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ANDE Stock Overview
Market Cap in USD | 1,468m |
Sector | Consumer Defensive |
Industry | Food Distribution |
GiC Sub-Industry | Food Distributors |
IPO / Inception | 1996-02-20 |
ANDE Stock Ratings
Growth 5y | 49.1% |
Fundamental | 4.69% |
Dividend | 54.7% |
Rel. Strength Industry | -26.1 |
Analysts | 5/5 |
Fair Price Momentum | 44.73 USD |
Fair Price DCF | 123.81 USD |
ANDE Dividends
Dividend Yield 12m | 2.13% |
Yield on Cost 5y | 6.86% |
Annual Growth 5y | -4.03% |
Payout Consistency | 99.2% |
ANDE Growth Ratios
Growth Correlation 3m | 15.1% |
Growth Correlation 12m | -88.2% |
Growth Correlation 5y | 87.5% |
CAGR 5y | 24.49% |
CAGR/Max DD 5y | 0.50 |
Sharpe Ratio 12m | -0.84 |
Alpha | -27.36 |
Beta | 0.48 |
Volatility | 38.58% |
Current Volume | 230.6k |
Average Volume 20d | 297.1k |
As of March 15, 2025, the stock is trading at USD 41.91 with a total of 230,635 shares traded.
Over the past week, the price has changed by -2.83%, over one month by +3.35%, over three months by -3.79% and over the past year by -20.04%.
Neither. Based on ValueRay Fundamental Analyses, The Andersons is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 4.69 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ANDE as of March 2025 is 44.73. This means that ANDE is currently overvalued and has a potential downside of 6.73%.
The Andersons has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy ANDE.
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ANDE The Andersons will be worth about 48.3 in March 2026. The stock is currently trading at 41.91. This means that the stock has a potential upside of +15.27%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 62.5 | 49.1% |
Analysts Target Price | 65 | 55.1% |
ValueRay Target Price | 48.3 | 15.3% |